Hikma Pharmaceuticals PLC (LON:HIK) Declares Dividend Increase – $0.48 Per Share

Hikma Pharmaceuticals PLC (LON:HIK) announced a dividend on Wednesday, February 26th, DividendData.Co.Uk reports. Stockholders of record on Thursday, March 20th will be given a dividend of $0.48 per share on Thursday, May 1st. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 20th. This is a 50.0% increase from Hikma Pharmaceuticals’s previous dividend of $0.32. The official announcement can be viewed at this link.

Hikma Pharmaceuticals Price Performance

HIK traded up GBX 22 ($0.29) during trading hours on Tuesday, hitting GBX 2,052 ($26.65). The company’s stock had a trading volume of 76,300,625 shares, compared to its average volume of 3,417,024. The business’s 50-day moving average price is GBX 2,177.22 and its 200-day moving average price is GBX 2,014.40. Hikma Pharmaceuticals has a 12 month low of GBX 1,750 ($22.73) and a 12 month high of GBX 2,360 ($30.65). The stock has a market cap of £5.69 billion, a price-to-earnings ratio of 20.14, a P/E/G ratio of 2.38 and a beta of 0.41. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82.

Analyst Upgrades and Downgrades

HIK has been the topic of several research reports. Berenberg Bank restated a “buy” rating and issued a GBX 2,560 ($33.25) price target on shares of Hikma Pharmaceuticals in a research report on Monday, March 10th. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hikma Pharmaceuticals in a research report on Friday, March 7th.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.